Showing results (61-70 of 178) with videos related to
Sort By:
Pageof 18
Anticancer Research|January 29, 2011
Pharmacogenetic tailoring of irinotecan-based first-line chemotherapy in metastatic colorectal cancer: results of a pilot studyGilles Freyer, Aude Duret, Gerard Milano, et al.JAMA Network Open|December 21, 2021
Assessment of Treatment Effects and Long-term Benefits in Immune Checkpoint Inhibitor Trials Using the Flexible Parametric Cure Model: A Systematic ReviewThomas Filleron, Marine Bachelier, Julien Mazieres, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2011
Population analysis of erlotinib in adults and children reveals pharmacokinetic characteristics as the main factor explaining tolerance particularities in childrenMelanie White-Koning, Elodie Civade, Birgit Geoerger, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 28, 2010
Preclinical and clinical evidence that Deoxy-2-[18F]fluoro-D-glucose positron emission tomography with computed tomography is a reliable tool for the detection of early molecular responses to erlotinib in head and neck cancerSébastien Vergez, Jean-Pierre Delord, Fabienne Thomas, et al.Journal for Immunotherapy of Cancer|November 16, 2019
Anti-TNF, a magic bullet in cancer immunotherapy?Anne Montfort, Carine Dufau, Céline Colacios, et al.European Journal of Cancer (Oxford, England : 1990)|June 16, 2009
Population pharmacokinetics of erlotinib and its pharmacokinetic/pharmacodynamic relationships in head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Melanie White-Koning, et al.Cancer Letters|July 25, 2012
Ovarian ascites-derived Hospicells promote angiogenesis via activation of macrophagesMagali Castells, Benoît Thibault, Eliane Mery, et al.Cancer Chemotherapy and Pharmacology|October 24, 2018
Phase I trial of afatinib and 3-weekly trastuzumab with optimal anti-diarrheal management in patients with HER2-positive metastatic cancerNicolas Martin, Nicolas Isambert, Carlos Gomez-Roca, et al.European Journal of Nuclear Medicine and Molecular Imaging|November 5, 2014
Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome?Laurent Dercle, Roland Chisin, Samy Ammari, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 7, 2007
Pilot study of neoadjuvant treatment with erlotinib in nonmetastatic head and neck squamous cell carcinomaFabienne Thomas, Philippe Rochaix, Adil Benlyazid, et al.Pageof 18